The Trading Window of the Company shall remain closed with effect from October 1, 2025 until the expiry of 48 hours after the declaration of financial results for the quarter and half year ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has informed BSE that its trading window will remain closed from October 1, 2025, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2025. This is a mandatory compliance measure under Clause 4 of Schedule B of SEBI's Prohibition of Insider Trading Regulations, 2015. The closure is aimed at preventing insiders from trading the stock while in possession of unpublished price-sensitive information ahead of the results. The communication has been signed by Company Secretary Nirav Shah. No insider trades, share pledging, or changes in shareholding are being disclosed in this filing.
This is a routine regulatory announcement and is not expected to have any direct impact on shareholders or the stock price. It simply restricts designated persons from trading the stock until the upcoming financial results are publicly announced and digested by the market.